Marathon Pharmaceuticals, LLC, Is known as a biopharmaceutical company that researches, develops, makes treatments for rare neurological and disorders dealing with the muscular part of the body. Founded in 2008 and is based in Northbrook, Illinois. They also have additional offices in Chicago, New Jersey, and Washington D.C. Their target market focused on extremely rare muscular diseases, impacting fewer than 200,000 patients in the United States. Since their focus was on late-stage drugs they received the regulatory approvals needed and was able to manufacture and commercialized the medicines with direct impact to their focused patients. They also provided assistance to eligible patients with financial hardships and help secure assistance through the National Organizations of Rare Disorders (NORD) and similar patient support groups.
They specialize in treating rare diseases of the muscles; including muscular dystrophy, inflammatory myopathy and arthritis. While they do treat other diseases of the muscles their focus is mainly in therapeutics. Since their Inception Marathon Pharma has created several medicines that helped ailing patients be comforted and were able to manage movement better because of their groundbreaking treatments. They conducted over 15 new preclinical and clinical studies in support of their new drug being submitted to the FDA. The folks at Marathon Pharmaceutical were able to obtain a great amount of support when it came to the investing into the research of the medicines they created for patients. Their post market research added to popular use of the drug. One particular study examined the various dose regimens in younger patients to determine if the intervention was safe for use, and it was. A second study examined various dose regimens in non-ambulatory patients to see what the side effects were in pulmonary and cardiac After Effects. They were very successful.
Until recently changes in the market and pricing in the pharma industry, therapeutics and drugs have changed drastically. Marathon has had to make some changes and sell-off part of their company. Ultimately, putting a hold on many of their product launches that were planned for the previous year. Marathon Pharmaceuticals makes drugs for patients that are truly suffering with their degenerative diseases let’s keep our fingers crossed that Marathon can muscle through and make an ultimate comeback!